These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1878654)

  • 21. A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring.
    Vessey MP; Fairweather DV; Norman-Smith B; Buckley J
    Br J Obstet Gynaecol; 1983 Nov; 90(11):1007-17. PubMed ID: 6357269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical and psychological effects of DES on exposed offspring.
    Konicki AM
    Cancer Nurs; 1985 Aug; 8(4):233-7. PubMed ID: 3850790
    [No Abstract]   [Full Text] [Related]  

  • 23. The Diethylstilbestrol Legacy: A Powerful Case Against Intervention in Uncomplicated Pregnancy.
    Troisi R; Hatch EE; Titus L
    Pediatrics; 2016 Nov; 138(Suppl 1):S42-S44. PubMed ID: 27940976
    [No Abstract]   [Full Text] [Related]  

  • 24. Genital clear cell adenocarcinoma.
    Johnston GA; Jones HA
    Int Surg; 1983; 68(3):257-61. PubMed ID: 6662641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project.
    Robboy SJ; Noller KL; O'Brien P; Kaufman RH; Townsend D; Barnes AB; Gundersen J; Lawrence WD; Bergstrahl E; McGorray S
    JAMA; 1984 Dec; 252(21):2979-83. PubMed ID: 6502858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA
    Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of cervical and vaginal squamous cell neoplasia as a late consequence of in utero exposure to diethylstilbestrol.
    Bornstein J; Adam E; Adler-Storthz K; Kaufman RH
    Obstet Gynecol Surv; 1988 Jan; 43(1):15-21. PubMed ID: 2829071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DES exposure and the aging woman: mothers and daughters.
    Laitman CJ
    Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leads from the MMWR. Report of the recommendations of the 1985 DES Task Force of the US Department of Health and Human Services.
    JAMA; 1986 Apr; 255(14):1849, 1853. PubMed ID: 3951105
    [No Abstract]   [Full Text] [Related]  

  • 30. Report of the recommendations of the 1985 DES Task Force of the U.S. Department of Health and Human Services.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):155-6, 161-2. PubMed ID: 3081782
    [No Abstract]   [Full Text] [Related]  

  • 31. Stilboestrol and human cancer.
    Bishun NP; Smith NS; Williams DC
    Clin Oncol; 1977 Mar; 3(1):75-80. PubMed ID: 862278
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    J Fla Med Assoc; 1977 Feb; 64(2):96-8. PubMed ID: 839195
    [No Abstract]   [Full Text] [Related]  

  • 33. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risks of cervical intraepithelial neoplasia among DES-exposed women.
    Fowler WC; Schmidt G; Edelman DA; Kaufman DG; Fenoglio CM
    Obstet Gynecol; 1981 Dec; 58(6):720-4. PubMed ID: 7312237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial: Mesonephric carcinoma of cervix.
    Carrier TC
    Minn Med; 1974 Apr; 57(4):295. PubMed ID: 4827617
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
    Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
    Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Squamous papilloma arising in cervical ectropion associated with intrauterine diethylstilbestrol exposure.
    Chen KT; Bocian JJ
    Diagn Gynecol Obstet; 1982; 4(2):137-9. PubMed ID: 7094820
    [No Abstract]   [Full Text] [Related]  

  • 38. Premenopausal breast cancer after in-utero exposure to stilboestrol.
    Huckell C; Laskin J; Gelmon K
    Lancet; 1996 Aug; 348(9023):331. PubMed ID: 8709698
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaginal and cervical cancers associated with exposure in utero to diethylstilbestrol.
    J Med Soc N J; 1977 Jan; 74(1):68-70. PubMed ID: 264577
    [No Abstract]   [Full Text] [Related]  

  • 40. DES clinic--the first six months.
    Wingfield M; Donnelly VS; Kelehan P; Stronge JM; Murphy J; Boylan P
    Ir Med J; 1992 Jun; 85(2):56-8. PubMed ID: 1628942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.